Endothelial nitric oxide synthase regulates microvascular hyperpermeability <i>in vivo</i>

dc.contributor.authorHatakeyama, Takuya
dc.contributor.authorPappas, Peter J.
dc.contributor.authorHobson, Robert W., II
dc.contributor.authorBoric, Mauricio P.
dc.contributor.authorSessa, William C.
dc.contributor.authorDuran, Walter N.
dc.date.accessioned2025-01-21T01:06:04Z
dc.date.available2025-01-21T01:06:04Z
dc.date.issued2006
dc.description.abstractNitric oxide (NO) is an important regulator of blood flow, but its role in permeability is still challenged. We tested in vivo the hypotheses that: (a) endothelial nitric oxide synthase (eNOS) is not essential for regulation of baseline permeability; (b) eNOS is essential for hyperpermeability responses in inflammation; and (c) molecular inhibition of eNOS with caveolin-1 scaffolding domain (AP-Cav) reduces eNOS-regulated hyperpermeability. We used eNOS-deficient (eNOS-/-) mice and their wild-type control as experimental animals, platelet-activating factor (PAF) at 10(-7) m as the test pro-inflammatory agent, and integrated optical intensity (IOI) as an index of microvascular permeability. PAF increased permeability in wild-type cremaster muscle from a baseline of 2.4 +/- 2.2 to a peak net value of 84.4 +/- 2.7 units, while the corresponding values in cremaster muscle of eNOS-/- mice were 1.0 +/- 0.3 and 15.6 +/- 7.7 units (P < 0.05). Similarly, PAF increased IOI in the mesentery of wild-type mice but much less in the mesentery of eNOS-/- mice. PAF increased IOI to comparable values in the mesenteries of wild-type mice and those lacking the gene for inducible NOS (iNOS). Administration of AP-Cav blocked the microvascular hyperpermeability responses to 10(-7) m PAF. We conclude that: (1) baseline permeability does not depend on eNOS; (2) eNOS and NO are integral elements of the signalling pathway for the hyperpermeability response to PAF; (3) iNOS does not affect either baseline permeability or hyperpermeability responses to PAF; and (4) caveolin-1 inhibits eNOS regulation of microvascular permeability in vivo. Our results establish eNOS as an important regulator of microvascular permeability in inflammation.
dc.description.funderNHLBI NIH HHS
dc.fuente.origenWOS
dc.identifier.doi10.1113/jphysiol.2006.108175
dc.identifier.eissn1469-7793
dc.identifier.issn0022-3751
dc.identifier.urihttps://doi.org/10.1113/jphysiol.2006.108175
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/96083
dc.identifier.wosidWOS:000239011300024
dc.issue.numero1
dc.language.isoen
dc.pagina.final281
dc.pagina.inicio275
dc.revistaJournal of physiology-london
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleEndothelial nitric oxide synthase regulates microvascular hyperpermeability <i>in vivo</i>
dc.typeartículo
dc.volumen574
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files